readthroughSign in
CompanyCGENNasdaqHolon, L3

Compugen Ltd

Compugen is a clinical-stage company developing cancer immunotherapies using its Unigen AI/ML platform.

6-KSep 28Latest SEC filing
Aug 3Latest story

August 2026